IBDEI0JB ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25969,2)
 ;;=^15310
 ;;^UTILITY(U,$J,358.3,25970,0)
 ;;=369.01^^165^1540^109
 ;;^UTILITY(U,$J,358.3,25970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25970,1,3,0)
 ;;=3^Total Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,25970,1,4,0)
 ;;=4^369.01
 ;;^UTILITY(U,$J,358.3,25970,2)
 ;;=^268861
 ;;^UTILITY(U,$J,358.3,25971,0)
 ;;=369.02^^165^1540^75
 ;;^UTILITY(U,$J,358.3,25971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25971,1,3,0)
 ;;=3^One Eye-Near Total/Oth Eye-NOS
 ;;^UTILITY(U,$J,358.3,25971,1,4,0)
 ;;=4^369.02
 ;;^UTILITY(U,$J,358.3,25971,2)
 ;;=^268862
 ;;^UTILITY(U,$J,358.3,25972,0)
 ;;=369.03^^165^1540^74
 ;;^UTILITY(U,$J,358.3,25972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25972,1,3,0)
 ;;=3^One Eye-Near Total/Oth Eye Total
 ;;^UTILITY(U,$J,358.3,25972,1,4,0)
 ;;=4^369.03
 ;;^UTILITY(U,$J,358.3,25972,2)
 ;;=^268863
 ;;^UTILITY(U,$J,358.3,25973,0)
 ;;=369.04^^165^1540^64
 ;;^UTILITY(U,$J,358.3,25973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25973,1,3,0)
 ;;=3^Near Total Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,25973,1,4,0)
 ;;=4^369.04
 ;;^UTILITY(U,$J,358.3,25973,2)
 ;;=^268864
 ;;^UTILITY(U,$J,358.3,25974,0)
 ;;=369.06^^165^1540^77
 ;;^UTILITY(U,$J,358.3,25974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25974,1,3,0)
 ;;=3^One Eye-Profound,Oth Eye-Total
 ;;^UTILITY(U,$J,358.3,25974,1,4,0)
 ;;=4^369.06
 ;;^UTILITY(U,$J,358.3,25974,2)
 ;;=^268866
 ;;^UTILITY(U,$J,358.3,25975,0)
 ;;=369.07^^165^1540^76
 ;;^UTILITY(U,$J,358.3,25975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25975,1,3,0)
 ;;=3^One Eye-Profound,Oth Eye-Near
 ;;^UTILITY(U,$J,358.3,25975,1,4,0)
 ;;=4^369.07
 ;;^UTILITY(U,$J,358.3,25975,2)
 ;;=^268867
 ;;^UTILITY(U,$J,358.3,25976,0)
 ;;=369.08^^165^1540^91
 ;;^UTILITY(U,$J,358.3,25976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25976,1,3,0)
 ;;=3^Profound Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,25976,1,4,0)
 ;;=4^369.08
 ;;^UTILITY(U,$J,358.3,25976,2)
 ;;=^268868
 ;;^UTILITY(U,$J,358.3,25977,0)
 ;;=369.10^^165^1540^73
 ;;^UTILITY(U,$J,358.3,25977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25977,1,3,0)
 ;;=3^One Eye-Blind,Oth-Low Vision
 ;;^UTILITY(U,$J,358.3,25977,1,4,0)
 ;;=4^369.10
 ;;^UTILITY(U,$J,358.3,25977,2)
 ;;=^268870
 ;;^UTILITY(U,$J,358.3,25978,0)
 ;;=369.11^^165^1540^78
 ;;^UTILITY(U,$J,358.3,25978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25978,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Blind
 ;;^UTILITY(U,$J,358.3,25978,1,4,0)
 ;;=4^369.11
 ;;^UTILITY(U,$J,358.3,25978,2)
 ;;=^268871
 ;;^UTILITY(U,$J,358.3,25979,0)
 ;;=369.12^^165^1540^81
 ;;^UTILITY(U,$J,358.3,25979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25979,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Total
 ;;^UTILITY(U,$J,358.3,25979,1,4,0)
 ;;=4^369.12
 ;;^UTILITY(U,$J,358.3,25979,2)
 ;;=^268872
 ;;^UTILITY(U,$J,358.3,25980,0)
 ;;=369.13^^165^1540^79
 ;;^UTILITY(U,$J,358.3,25980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25980,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Near Total
 ;;^UTILITY(U,$J,358.3,25980,1,4,0)
 ;;=4^369.13
 ;;^UTILITY(U,$J,358.3,25980,2)
 ;;=^268873
 ;;^UTILITY(U,$J,358.3,25981,0)
 ;;=369.14^^165^1540^80
 ;;^UTILITY(U,$J,358.3,25981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25981,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Profound
 ;;^UTILITY(U,$J,358.3,25981,1,4,0)
 ;;=4^369.14
 ;;^UTILITY(U,$J,358.3,25981,2)
 ;;=^268874
 ;;^UTILITY(U,$J,358.3,25982,0)
 ;;=369.22^^165^1540^101
 ;;^UTILITY(U,$J,358.3,25982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25982,1,3,0)
 ;;=3^Severe Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,25982,1,4,0)
 ;;=4^369.22
 ;;^UTILITY(U,$J,358.3,25982,2)
 ;;=^268882
 ;;^UTILITY(U,$J,358.3,25983,0)
 ;;=369.60^^165^1540^6
 ;;^UTILITY(U,$J,358.3,25983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25983,1,3,0)
 ;;=3^Blindness,One Eye Only
 ;;^UTILITY(U,$J,358.3,25983,1,4,0)
 ;;=4^369.60
 ;;^UTILITY(U,$J,358.3,25983,2)
 ;;=^268880
 ;;^UTILITY(U,$J,358.3,25984,0)
 ;;=369.9^^165^1540^114
 ;;^UTILITY(U,$J,358.3,25984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25984,1,3,0)
 ;;=3^Visual Loss NOS
 ;;^UTILITY(U,$J,358.3,25984,1,4,0)
 ;;=4^369.9
 ;;^UTILITY(U,$J,358.3,25984,2)
 ;;=^126769
 ;;^UTILITY(U,$J,358.3,25985,0)
 ;;=377.61^^165^1540^20
 ;;^UTILITY(U,$J,358.3,25985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25985,1,3,0)
 ;;=3^D/O Pathways w/ Neoplasm
 ;;^UTILITY(U,$J,358.3,25985,1,4,0)
 ;;=4^377.61
 ;;^UTILITY(U,$J,358.3,25985,2)
 ;;=^269241
 ;;^UTILITY(U,$J,358.3,25986,0)
 ;;=379.02^^165^1540^68
 ;;^UTILITY(U,$J,358.3,25986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25986,1,3,0)
 ;;=3^Nodular Episcleritis
 ;;^UTILITY(U,$J,358.3,25986,1,4,0)
 ;;=4^379.02
 ;;^UTILITY(U,$J,358.3,25986,2)
 ;;=^269285
 ;;^UTILITY(U,$J,358.3,25987,0)
 ;;=379.07^^165^1540^89
 ;;^UTILITY(U,$J,358.3,25987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25987,1,3,0)
 ;;=3^Posterior Scleritis
 ;;^UTILITY(U,$J,358.3,25987,1,4,0)
 ;;=4^379.07
 ;;^UTILITY(U,$J,358.3,25987,2)
 ;;=^269295
 ;;^UTILITY(U,$J,358.3,25988,0)
 ;;=379.92^^165^1540^105
 ;;^UTILITY(U,$J,358.3,25988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25988,1,3,0)
 ;;=3^Swelling/Mass of Eye
 ;;^UTILITY(U,$J,358.3,25988,1,4,0)
 ;;=4^379.92
 ;;^UTILITY(U,$J,358.3,25988,2)
 ;;=^269334
 ;;^UTILITY(U,$J,358.3,25989,0)
 ;;=379.93^^165^1540^93
 ;;^UTILITY(U,$J,358.3,25989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25989,1,3,0)
 ;;=3^Redness/Discharge of Eye
 ;;^UTILITY(U,$J,358.3,25989,1,4,0)
 ;;=4^379.93
 ;;^UTILITY(U,$J,358.3,25989,2)
 ;;=^104154
 ;;^UTILITY(U,$J,358.3,25990,0)
 ;;=379.99^^165^1540^85
 ;;^UTILITY(U,$J,358.3,25990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25990,1,3,0)
 ;;=3^Oth Ill-Defined Eye D/O
 ;;^UTILITY(U,$J,358.3,25990,1,4,0)
 ;;=4^379.99
 ;;^UTILITY(U,$J,358.3,25990,2)
 ;;=^269335
 ;;^UTILITY(U,$J,358.3,25991,0)
 ;;=555.9^^165^1540^94
 ;;^UTILITY(U,$J,358.3,25991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25991,1,3,0)
 ;;=3^Regional Enteritis,Unspec
 ;;^UTILITY(U,$J,358.3,25991,1,4,0)
 ;;=4^555.9
 ;;^UTILITY(U,$J,358.3,25991,2)
 ;;=^29356
 ;;^UTILITY(U,$J,358.3,25992,0)
 ;;=696.1^^165^1540^92
 ;;^UTILITY(U,$J,358.3,25992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25992,1,3,0)
 ;;=3^Psoriasis
 ;;^UTILITY(U,$J,358.3,25992,1,4,0)
 ;;=4^696.1
 ;;^UTILITY(U,$J,358.3,25992,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,25993,0)
 ;;=709.2^^165^1540^39
 ;;^UTILITY(U,$J,358.3,25993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25993,1,3,0)
 ;;=3^Facial Scar
 ;;^UTILITY(U,$J,358.3,25993,1,4,0)
 ;;=4^709.2
 ;;^UTILITY(U,$J,358.3,25993,2)
 ;;=^108131
 ;;^UTILITY(U,$J,358.3,25994,0)
 ;;=710.0^^165^1540^60
 ;;^UTILITY(U,$J,358.3,25994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25994,1,3,0)
 ;;=3^Lupus,Systemic Erythmatosis
 ;;^UTILITY(U,$J,358.3,25994,1,4,0)
 ;;=4^710.0
 ;;^UTILITY(U,$J,358.3,25994,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,25995,0)
 ;;=710.9^^165^1540^10
 ;;^UTILITY(U,$J,358.3,25995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25995,1,3,0)
 ;;=3^Collagen Disease NOS
 ;;^UTILITY(U,$J,358.3,25995,1,4,0)
 ;;=4^710.9
 ;;^UTILITY(U,$J,358.3,25995,2)
 ;;=^123811
 ;;^UTILITY(U,$J,358.3,25996,0)
 ;;=714.0^^165^1540^97
 ;;^UTILITY(U,$J,358.3,25996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25996,1,3,0)
 ;;=3^Rheumatoid Arthritis
 ;;^UTILITY(U,$J,358.3,25996,1,4,0)
 ;;=4^714.0
 ;;^UTILITY(U,$J,358.3,25996,2)
 ;;=^10473
 ;;^UTILITY(U,$J,358.3,25997,0)
 ;;=714.30^^165^1540^98
 ;;^UTILITY(U,$J,358.3,25997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25997,1,3,0)
 ;;=3^Rheumatoid Arthritis,Juvenile
 ;;^UTILITY(U,$J,358.3,25997,1,4,0)
 ;;=4^714.30
 ;;^UTILITY(U,$J,358.3,25997,2)
 ;;=^24424
 ;;^UTILITY(U,$J,358.3,25998,0)
 ;;=744.89^^165^1540^38
 ;;^UTILITY(U,$J,358.3,25998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25998,1,3,0)
 ;;=3^Face/Neck Anom NEC,Congenital
 ;;^UTILITY(U,$J,358.3,25998,1,4,0)
 ;;=4^744.89
 ;;^UTILITY(U,$J,358.3,25998,2)
 ;;=^272875
 ;;^UTILITY(U,$J,358.3,25999,0)
 ;;=759.6^^165^1540^115
 ;;^UTILITY(U,$J,358.3,25999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25999,1,3,0)
 ;;=3^Von-Hippel Lindau Disease
 ;;^UTILITY(U,$J,358.3,25999,1,4,0)
 ;;=4^759.6
 ;;^UTILITY(U,$J,358.3,25999,2)
 ;;=^87431
 ;;^UTILITY(U,$J,358.3,26000,0)
 ;;=759.82^^165^1540^62
 ;;^UTILITY(U,$J,358.3,26000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26000,1,3,0)
 ;;=3^Marfan Syndrome
 ;;^UTILITY(U,$J,358.3,26000,1,4,0)
 ;;=4^759.82
 ;;^UTILITY(U,$J,358.3,26000,2)
 ;;=^74034
 ;;^UTILITY(U,$J,358.3,26001,0)
 ;;=802.4^^165^1540^36
 ;;^UTILITY(U,$J,358.3,26001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26001,1,3,0)
 ;;=3^FX Malar/Maxillary Bones,Closed
 ;;^UTILITY(U,$J,358.3,26001,1,4,0)
 ;;=4^802.4
 ;;^UTILITY(U,$J,358.3,26001,2)
 ;;=^25312
 ;;^UTILITY(U,$J,358.3,26002,0)
 ;;=870.1^^165^1540^53
 ;;^UTILITY(U,$J,358.3,26002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26002,1,3,0)
 ;;=3^Laceration Full Thickness
 ;;^UTILITY(U,$J,358.3,26002,1,4,0)
 ;;=4^870.1
 ;;^UTILITY(U,$J,358.3,26002,2)
 ;;=^274880
 ;;^UTILITY(U,$J,358.3,26003,0)
 ;;=870.2^^165^1540^34
 ;;^UTILITY(U,$J,358.3,26003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26003,1,3,0)
 ;;=3^Eyelid Laceration Involving Lacrimal
 ;;^UTILITY(U,$J,358.3,26003,1,4,0)
 ;;=4^870.2
 ;;^UTILITY(U,$J,358.3,26003,2)
 ;;=^274881
 ;;^UTILITY(U,$J,358.3,26004,0)
 ;;=870.3^^165^1540^83
 ;;^UTILITY(U,$J,358.3,26004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26004,1,3,0)
 ;;=3^Orbital Wound,Penetrating
 ;;^UTILITY(U,$J,358.3,26004,1,4,0)
 ;;=4^870.3
 ;;^UTILITY(U,$J,358.3,26004,2)
 ;;=^274882
 ;;^UTILITY(U,$J,358.3,26005,0)
 ;;=870.9^^165^1540^69
 ;;^UTILITY(U,$J,358.3,26005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26005,1,3,0)
 ;;=3^Ocular Adnexa Open Wound,Unspec
 ;;^UTILITY(U,$J,358.3,26005,1,4,0)
 ;;=4^870.9
 ;;^UTILITY(U,$J,358.3,26005,2)
 ;;=^274885
 ;;^UTILITY(U,$J,358.3,26006,0)
 ;;=871.0^^165^1540^70
 ;;^UTILITY(U,$J,358.3,26006,1,0)
 ;;=^358.31IA^4^2
